NR3C2 and major depressive disorder: Interestingly, in MDD patients decreased MR expression has been found in the prefrontal cortex and hippocampus [48–50], and for the NMDA-R studies showed receptor downregulations in the prefrontal cortex and upregulations in the amygdala [51].